North America & Europe Sepsis Diagnostics Market To Reach $1.24 Billion By 2030

North America And Europe Sepsis Diagnostics Market Growth & Trends

The North America and Europe sepsis diagnostics market size is anticipated to reach USD 1.24 billion by 2030 and is anticipated to expand at a CAGR of 7.3% during the forecast period, according to a new report by Grand View Research, Inc. North America experiences a significant prevalence of sepsis, making it a leading cause of hospital deaths. This high incidence drives the demand for effective diagnostic solutions. Favorable reimbursement policies also encourage healthcare providers to adopt advanced diagnostics, while increased awareness and public-private funding boost the development of innovative tools.

In Europe, stringent regulations ensure reliable sepsis testing methods are available, supporting market growth. The aging population, more susceptible to infections, further escalates the demand for tailored diagnostic solutions. In addition, the rising healthcare spending enhances access to advanced diagnostics across European countries.

The European Centre for Disease Prevention and Control (ECDC) reported in 2024 that HAIs affected around 4.5 million patients annually, with sepsis as a major consequence. In 2023, the UK government allocated approximately USD 12 million for antimicrobial resistance (AMR) research, directly aiding sepsis management initiatives. Moreover, projected federal funding for sepsis-related programs in the U.S. was expected to exceed USD 50 million in 2024, aimed at improving diagnostic technologies and reducing mortality rates associated with sepsis.

 Request a free sample copy or view report summary: North America and Europe Sepsis Diagnostics Market Report

North America And Europe Sepsis Diagnostics Market Report Highlights

• Based on product, blood culture media held over 30.0% market share in 2023, while assay kits and reagents are poised for lucrative growth from 2025 to 2030 onwards

• Microbiology led the technology segment in 2024, while molecular diagnostics are anticipated to witness the fastest rate of 9.3% over the forecast period

• Based on pathogen, bacterial sepsis held the largest market share in 2024, driven by significant mortality rates, rising HAIs, and technological advancements. It is also expected to grow at the fastest CAGR over the forecast period

• Based on testing, POC testing is expected to grow at a staggering 9.6% CAGR as laboratory testing led the testing segment

• Based on method, automated diagnostic methods are expected to grow at the fastest CAGR over the forecast period

• The U.S. dominated the North America sepsis diagnostics market as the shift to value-based care promotes early detection, while supportive reimbursement, increased awareness, and government initiatives enhance sepsis management innovations.

• The UK sepsis diagnostics market is expected to grow at the fastest rate of 8.1% over the forecast period in the Europe market

• In March 2024, BD collaborated with GOCC in Poland to enhance access to advanced bloodstream infection testing, deploying state-of-the-art microbiology equipment across over 150 hospitals and clinics for improved sepsis management

North America And Europe Sepsis Diagnostics Market Segmentation

Grand View Research has segmented the North America and Europe sepsis diagnostics market based on product, technology, pathogen, testing, method, end use, and region:

North America And Europe Sepsis Diagnostics Product Outlook (Revenue, USD Million, 2018 - 2030)

• Instruments

• Blood Culture Media

• Assay Kits and Reagents

• Software

North America And Europe Sepsis Diagnostics Technology Outlook (Revenue, USD Million, 2018 - 2030)

• Microbiology

• Molecular Diagnostics

  • Polymerase Chain Reaction (PCR)

  • DNA Microarrays

  • Syndromic Panel Testing

  • Others

• Immunoassays

• Flow Cytometry

• Others

North America And Europe Sepsis Diagnostics Pathogen Outlook (Revenue, USD Million, 2018 - 2030)

• Bacterial Sepsis

  • Gram-positive Bacteria

  • Gram-negative Bacteria

• Fungal Sepsis

• Viral Sepsis

• Others

North America And Europe Sepsis Diagnostics Testing Outlook (Revenue, USD Million, 2018 - 2030)

• Laboratory Testing

• PoC Testing

North America And Europe Sepsis Diagnostics Method Outlook (Revenue, USD Million, 2018 - 2030)

• Automated Diagnostics

• Conventional Diagnostics

North America And Europe Sepsis Diagnostics End Use Outlook (Revenue, USD Million, 2018 - 2030)

• Hospitals & Clinics

• Pathology & Reference Laboratories

• Research Institutes and Others

North America And Europe Sepsis Diagnostics Region Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Russia

  • Denmark

  • Sweden

  • Norway

List of Key Players in the North America And Europe Sepsis Diagnostics Market

• BD

• bioMérieux SA

• Thermo Fisher Scientific Inc.

• Beckman Coulter, Inc. (Danaher Corporation)

• F. Hoffmann-La Roche Ltd

• Cepheid

• Luminex Corp.

• Koninklijke Philips N.V.

• Bruker

• Immunexpress Inc.